Articles published by Can-Fite BioPharma Ltd.Via Business Wire
Tickers
CANF
Via Business Wire
Tickers
CANF
Can-Fite Announces $7.5 Million Concurrent Registered Direct Offering and Private Placement
January 11, 2023
Via Business Wire
Tickers
CANF
Can-Fite Updates: Namodenoson Increases Survival for the Most Severe Patients with Advanced Liver Cancer
December 28, 2022
Via Business Wire
Tickers
CANF
Via Business Wire
Tickers
CANF
Can-Fite to Present its Phase IIb NASH Drug Candidate Namodenoson at Upcoming Conference
October 13, 2022
Via Business Wire
Tickers
CANF
Via Business Wire
Tickers
CANF
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|